elucidated that PD-L1+ TAMs expressed both the pro-tumor markers CD204, CD206, and CD163, as well as the anti-tumor marker CD169, indicating that PD-L1+ TAMs have a dualistic nature (67). Here, SIGLEC1 is linked to neoplasm.